By | December 31, 2014

Pharmaceutical News Wrap Up: December 2014

The pharmaceutical attorneys at Simmons Hanly Conroy understand the importance of staying up to date on the latest headlines. Below is a list of some of the most recent pharmaceutical news concerning… Read More

By | December 30, 2014

Asbestos and Mesothelioma News Wrap Up: December 2014

The mesothelioma lawyers at Simmons Hanly Conroy understand the importance of staying up to date on the latest asbestos and mesothelioma news. Below is a group of some of the most recent… Read More

By | December 18, 2014

FDA Advisers Shown to Have Questionable Financial Ties

In July 2014, an adviser on a U.S. Food and Drug Administration (FDA) gynecology panel stepped down after he was questioned about conflicts of interest. It was later discovered that this panel… Read More

By | December 17, 2014

The History of Risperdal FDA Warnings

Risperdal was approved by the U.S. Food and Drug Administration (FDA) in 1994. It is recognized as a medication used to treat psychological issues. The antipsychotic drug is approved for use in patients… Read More

By | December 17, 2014

Get to Know the Simmons Hanly Conroy Shareholders – Part 2

In October, we introduced ten members of the Simmons Hanly Conroy leadership team. Now it’s time to introduce ten more. By getting to know our shareholders, you can see for yourself the… Read More

By | December 16, 2014

Blood Thinners Like Xarelto and Pradaxa Classified as “Dangerous”: Here’s Why

Both Xarelto and Pradaxa are popular blood thinners prescribed to reduce the risk of blood clots that can cause a stroke or heart attack. These types of medications, however, come with serious… Read More

By | December 12, 2014

Holiday Storage in Attics and Asbestos Exposure: What to Know

It’s that time of year – people are heading upstairs to the attic or other storage space to fumble through their holiday décor and wrapping essentials. They’re pulling out boxes, shifting large… Read More

By | November 29, 2014

Asbestos and Mesothelioma News Wrap Up: November 2014

Here at Simmons Hanly Conroy, our asbestos attorneys want to keep you up to date on the latest asbestos and mesothelioma news. Below is a list of some of the most recent… Read More

By | November 26, 2014

Pharmaceutical News Wrap Up: November 2014

Here at Simmons Hanly Conroy, our pharmaceutical lawyers understand the importance of staying up to date on the latest pharmaceutical news. Below is a list of some of the most recent headlines concerning… Read More

By | November 24, 2014

6 Grain Industry Businesses Impacted by Viptera® Corn

Sales of Syngenta’s Agrisure Viptera® corn prior to approval for import by China has damaged the U.S. corn industry. The National Grain and Feed Association (NGFA) has estimated that the U.S. corn… Read More

Topics

PAST ARTICLES